| pubmed-article:15082201 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15082201 | lifeskim:mentions | umls-concept:C0007138 | lld:lifeskim |
| pubmed-article:15082201 | lifeskim:mentions | umls-concept:C0699885 | lld:lifeskim |
| pubmed-article:15082201 | lifeskim:mentions | umls-concept:C0008633 | lld:lifeskim |
| pubmed-article:15082201 | lifeskim:mentions | umls-concept:C0178874 | lld:lifeskim |
| pubmed-article:15082201 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:15082201 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:15082201 | pubmed:dateCreated | 2004-4-14 | lld:pubmed |
| pubmed-article:15082201 | pubmed:abstractText | The main prognostic factor generally accepted for tumour progression in T1 transitional cell carcinoma (TCC) of the bladder is histological grade. Despite this fact it is considered inaccurate to make clinical decisions on individuals. It appears that progression from minimally invasive to deeply invasive cancer is concurrent with the acquisition of genomic alterations that increase the malignant potential of cancer cells. The aim of this study is to determine if changes in chromosomes 7, 8, 9 and 17 copy number can be used to predict recurrence and progression in patients with T1 TCC of the urinary bladder. | lld:pubmed |
| pubmed-article:15082201 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15082201 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15082201 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15082201 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15082201 | pubmed:month | May | lld:pubmed |
| pubmed-article:15082201 | pubmed:issn | 0302-2838 | lld:pubmed |
| pubmed-article:15082201 | pubmed:author | pubmed-author:GelabertAA | lld:pubmed |
| pubmed-article:15082201 | pubmed:author | pubmed-author:PalouJJ | lld:pubmed |
| pubmed-article:15082201 | pubmed:author | pubmed-author:Villavicencio... | lld:pubmed |
| pubmed-article:15082201 | pubmed:author | pubmed-author:Lopez-Guiller... | lld:pubmed |
| pubmed-article:15082201 | pubmed:author | pubmed-author:AlcarazAA | lld:pubmed |
| pubmed-article:15082201 | pubmed:author | pubmed-author:MallofréCC | lld:pubmed |
| pubmed-article:15082201 | pubmed:author | pubmed-author:CarrilDD | lld:pubmed |
| pubmed-article:15082201 | pubmed:author | pubmed-author:MengualLL | lld:pubmed |
| pubmed-article:15082201 | pubmed:author | pubmed-author:RibalM JMJ | lld:pubmed |
| pubmed-article:15082201 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15082201 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:15082201 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15082201 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15082201 | pubmed:pagination | 593-9 | lld:pubmed |
| pubmed-article:15082201 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:meshHeading | pubmed-meshheading:15082201... | lld:pubmed |
| pubmed-article:15082201 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15082201 | pubmed:articleTitle | Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder. | lld:pubmed |
| pubmed-article:15082201 | pubmed:affiliation | Department of Urology, Fundació Puigvert, C/Cartagena, 340, 08025 Barcelona, Spain. mjribal@fundacio-puigvert.es | lld:pubmed |
| pubmed-article:15082201 | pubmed:publicationType | Journal Article | lld:pubmed |
